The latest price target for PureTech Health (NASDAQ:PRTC) was reported by Leerink Partners on September 9, 2024. The analyst firm set a price target for $45.00 expecting PRTC to rise to within 12 months (a possible 112.26% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for PureTech Health (NASDAQ:PRTC) was provided by Leerink Partners, and PureTech Health their outperform rating.

There is no last upgrade for PureTech Health

There is no last downgrade for PureTech Health.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PureTech Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PureTech Health was filed on September 9, 2024 so you should expect the next rating to be made available sometime around September 9, 2025.

While ratings are subjective and will change, the latest PureTech Health (PRTC) rating was a with a price target of $0.00 to $45.00. The current price PureTech Health (PRTC) is trading at is $21.20, which is within the analyst’s predicted range.